DOCSLIB.ORG

Formation of Apoptosis‐Inducing Amyloid Fibrils by Tryptophan

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Formation of Apoptosis‐Inducing Amyloid Fibrils by Tryptophan Full Paper DOI:10.1002/ijch.201600076 Formation of Apoptosis-Inducing Amyloid Fibrils by Tryptophan Shira Shaham-Niv,[a] Pavel Rehak,[b] Lela Vukovic´,[c] Lihi Adler-Abramovich,[d] Petr Krµl,[b,e,f] and Ehud Gazit*[a, g] Abstract:Manymajor degenerative disorders are associated Furthermore, the assembliesshow significant cytotoxicity with the formationofamyloidfibrils by proteins and pep- triggered by an apoptosis mechanism, similar to that known tides. Recent studies have extended the repertoire of amyloi- for amyloids.Asacontrol, the non-amyloidogenic amino dogenic building blocks to non-proteinaceous entities, in- acid alanine was used under the same conditionsand did cluding aminoacids and nucleobases. Here, based on the not show any toxicity.Molecular dynamics simulationswere high propensity of tryptophan-containing proteins and pep- used to explore the possible growth mechanism, molecular tides to form amyloid fibrils, we explored the self-assembly organization,and stability of tryptophan amyloidalfibrils. profile of this amino acid. We discovered that tryptophan Taken together,weprovide further extensiontothe amyloid forms fibrillary assemblieswith adiameterof15–75 nm. hypothesis and additional indication for aknwonmecha- These fibrils bind the thioflavin Tamyloid-specific dye and nism of toxicity for both amyloid-associated and metabolic show atypicalspectrum of amyloid proteins uponbinding. disorders. Keywords: aggregation · amino acids · amyloids · cytotoxicity · metabolic disorders 1. Introduction brillar supramolecular assemblies have adiameter of 5– Over the pastdecade,the phenomenon of soluble protein 20 nm, are predominantly rich in b-sheet secondary struc- and peptide misfolding, leading to the formation of or- ture,and specifically bind dyes,such as thioflavin T dered amyloid fibrils,has been increasingly associated (ThT) and Congo red.[2] Interestingly,analysis of short with agreat variety of notable human disorders with un- functional fragmentsfrom unrelated amyloid-forming related etiology,includingAlzheimersdisease,Parkin- proteins and polypeptidesidentified aremarkable occur- sonsdisease,and type II diabetes.[1] All amyloid fibrils rence of aromatic residues.[3] Thearomatic residues most share auniqueset of similar biophysical and structural likely have an important role in the amyloidogenic pro- properties,despite being formed by adiverse and struc- cess and in the stabilizationofamyloidal structures by turally unrelated group of proteins and peptides.These fi- [a] S. Shaham-Niv,E.Gazit [e] P. Krµl Department of Molecular Microbiology and Biotechnology Department of Physics George S. Wise Faculty of Life Sciences University of Illinois at Chicago TelAviv University Chicago (USA) TelAviv 69978 (Israel) [f]P.Krµl [b] P. Rehak, P. Krµl Department of Biopharmaceutical Sciences Department of Chemistry University of Illinois at Chicago University of Illinois at Chicago Chicago (USA) Chicago (USA) [g] E. Gazit [c] L. Vukovic´ Department of Materials Science and Engineering Department of Chemistry Iby and Aladar Fleischman Faculty of Engineering University of Texas at El Paso TelAviv University El Paso (USA) TelAviv 69978 (Israel) [d] L. Adler-Abramovich Tel.:(+972) 3-640-9030 Department of Oral Biology e-mail:[email protected] The Goldschleger School of Dental Medicine Supporting information for this article is available on the WWW TelAviv University under http://dx.doi.org/10.1002/ijch.201600076. TelAviv 69978 (Israel) Isr.J.Chem. 2017,57, 729 –737 2017 Wiley-VCH Verlag GmbH &Co. KGaA, Weinheim 729 Full Paper geometricallyrestricted interactions betweenplanar aro- teine,phenylalanine,and tyrosinehave high aggregation matic chemical entities.Theseresidues can affect the potential,[11] in agreement with their potential aggregative morphology of the assemblies,accelerate their formation, property as isolated amino acids.[10] However, the highest improve their stability and reduce the minimal association propensity was calculated for tryptophan,[11] whichwas concentration.[4] It was previously shown that penta- and not found in our initial screen. In addition,the high ag- tetrapeptidescan form typical amyloid fibrils.Moreover, gregation ability of tryptophan was also shown in the con- the diphenylalaninedipeptide,the core recognition motif text of tripeptides,where the aminoacid exhibited high within the b-amyloid polypeptide,was found to form aggregation propensity when positioned in the N-termi- well-ordered nanotubular assemblies in aqueous solu- nal, middle,orC-terminal positions.[12] Thearomatic tion.[5] Lateron, these dipeptideassemblies were shown amino acid tryptophan (see Figure 1A) is essential for to share opticaland functional properties with amyloids humans, playing acrucial role in protein stability and rec- that were assembled from the full-length polypeptide.[6] ognition, despite its rarity in protein sequences.[13] Fur- Thepentapeptide- and tetrapeptide-based amyloid nano- thermore,tryptophan is acritical component of numerous assemblies were foundtobecytotoxic via an apoptotic metabolic pathways,being abiochemical precursor for se- cell death pathway,which indicates abiological generic rotonin, melatonin, and niacin.[14] Tryptophan is accumu- property and acommon mechanism of toxicity.[7] Thus lated in pathological conditions, such as several metabolic the minimal peptideassemblies appear to reflect both the disorders.The accumulation of tryptophan has been re- physicalaswell as functional properties of natural amy- ported in two inborn errors of metabolism, hypertrypto- loid fibrils. phanemia and Hartnup disease (see Table 1), both shown While the formationofcytotoxic supramolecular enti- to be rare and inherited autosomal recessive disorders. ties has previously been linked to proteins and peptides, Hypertryptophanemia occurs due to the inabilityofthe it was first demonstrated by our groupand later by others body to process tryptophan.Asaresult, there is amassive that phenylalanine,asasingle amino acid, can also self- buildupoftryptophan in the bloodand urine, which fur- assemble to form amyloid-like fibrils showing typical ul- ther leads to musculoskeletal effects and to behavioral trastructural, biophysical, and biochemical properties.[8] and developmental abnormalities.[15] Hartnup disease is Moreover, we revealed the connectionbetween these as- caused by damage to aneutral amino acid transporter, semblies and the accumulation of phenylalanine in phe- limited to the kidneys and small intestine, which affects nylketonuria (PKU), aknownmetabolic disorder.We the absorption of nonpolar amino acids,mainlytrypto- demonstrated that these phenylalanine assemblies are cy- phan. Thus,increasedlevels of tryptophanand indolic totoxic and that antibodies raised towardsthese species compounds are detectedinthe patients urine.Common deplete fibril toxicity.The generation of antibodies in symptoms include the development of arash on parts of aPKU mice model and the identification of aggregate de- the body exposed to the sun, mental retardation, head- posits in patients brains post mortem suggested apatho- aches,collapsing and fainting.[16] logical role of these assemblies.[8a] In light of the above findings,wescreened for condi- Metabolicdisorders,such as PKU,and more specifical- tions in whichtryptophan could form visible structures ly inbornerrors of metabolism, are the result of aflaw in and foundthat by increasingtryptophan concentration, asingle gene encodingfor metabolic enzymes.As using the same conditionsfor self-assembly as with other aresult, accumulating metabolites may interfere with the metabolites,wecould detect the formation of assemblies normal function of cells and tissues and thus cause severe in the test tube.The properties of these assemblies were abnormalities.Unlessthese inheriteddisorders are treat- further examined usinglower concentrations,similar to ed with avery strict diet,they may result in mentalretar- the ones used in our previousscreening. Herewepresent, dation and other developmental problems.Although for the first time,the ability of the single amino acid tryp- these disorders are individually considered very rare,col- tophan to form amyloid supramolecular assemblies.We lectively they constituteavery substantial part of pedia- characterized the tryptophan aggregates usingacombina- tric genetic diseases.[9] Recently,wehave extended the ge- tion of diverse biophysicaland biological assays,inaddi- neric amyloid hypothesis to includeadditional non-protei- tion to the use of molecular dynamics (MD)simulations naceous entities,includingamino acids and nucleobases. to modelthe fibril formationand stability.This work fur- We demonstrated the ability of these small metabolites to ther extends the generic amyloid hypothesis and gives fur- form amyloidal fibrils,sharingthe same biophysical prop- ther supporting evidence for the associationbetween me- erties,aspresented by electronmicroscopy and the ThT tabolite amyloidformationand metabolic pathologies. binding assay, and their clear apoptoticeffect on aneuro- nal cell model. These new findings introduceanew possi- ble amyloid-like mechanism of metabolic disorders,sug- 2. Experimental Results and Discussion gesting anew paradigm for these rare maladies.[10] Previous work that examined the amyloid aggregation In previous work that calculated the amyloidaggregation propensity of all 20 coded amino acids revealedthat cys- potential of all amino acids in the context of proteins and Isr.J.Chem. 2017,57, 729 –737 2017 Wiley-VCH
Load more

Recommended publications
  • Amyloid Like Aggregates Formed by the Self-Assembly of Proline And
    Please do not adjust margins Journal Name ARTICLE Amyloid like aggregates formed by the self-assembly of proline and Hydroxyproline Bharti Koshtia, Ramesh Singh Chilwalb, Vivekshinh Kshtriyaa, Shanka Walia c, Dhiraj Bhatiac, K.B. Joshib* and Nidhi Goura* a Department of Chemistry, Indrashil University, Mehsana, Gujarat, India b Department of Chemistry, Dr. Hari Singh Gour, Sagar University, Madhya Pradesh, India c Biological Engineering Discipline, Indian Institute of Technology Gandhinagar, Gujarat, India Abstract: Single amino acid based self-assembled structures have gained a lot of interest recently owing to their pathological significance in metabolite disorders. There is plethora of significant research work which illustrate amyloid like characteristics of assemblies formed by aggregation of single amino acids like Phenylalanine, Tyrosine, Tryptophan, Cysteine and Methionine and its implications in pathophysiology of single amino acid metabolic disorders like phenylketonuria, tyrosinemia, hypertryptophanemia, cystinuria and hypermethioninemia respectively. Hence, studying aggregation behaviour of single amino acids is very crucial to assess the underlying molecular mechanism behind metabolic disorders. In this manuscript we report for the very first time the aggregation properties of non-aromatic single amino acids Hydroxy-proline and Proline. The morphologies of these were studied extensively by Optical microscopy (OM), ThT binding fluorescence microscopy, Scanning Electron Microscopy (SEM) and Atomic force microscopy (AFM). It can be assessed that these amino acids form globular structures at lower concentrations and gradually changes to tape like structures on increasing the This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 1 Please do not adjust margins Please do not adjust margins Journal Name ARTICLE concentration as assessed by AFM.
    [Show full text]
  • Amino Acid Disorders
    471 Review Article on Inborn Errors of Metabolism Page 1 of 10 Amino acid disorders Ermal Aliu1, Shibani Kanungo2, Georgianne L. Arnold1 1Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; 2Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA Contributions: (I) Conception and design: S Kanungo, GL Arnold; (II) Administrative support: S Kanungo; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: E Aliu, GL Arnold; (V) Data analysis and interpretation: None; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Georgianne L. Arnold, MD. UPMC Children’s Hospital of Pittsburgh, 4401 Penn Avenue, Suite 1200, Pittsburgh, PA 15224, USA. Email: [email protected]. Abstract: Amino acids serve as key building blocks and as an energy source for cell repair, survival, regeneration and growth. Each amino acid has an amino group, a carboxylic acid, and a unique carbon structure. Human utilize 21 different amino acids; most of these can be synthesized endogenously, but 9 are “essential” in that they must be ingested in the diet. In addition to their role as building blocks of protein, amino acids are key energy source (ketogenic, glucogenic or both), are building blocks of Kreb’s (aka TCA) cycle intermediates and other metabolites, and recycled as needed. A metabolic defect in the metabolism of tyrosine (homogentisic acid oxidase deficiency) historically defined Archibald Garrod as key architect in linking biochemistry, genetics and medicine and creation of the term ‘Inborn Error of Metabolism’ (IEM). The key concept of a single gene defect leading to a single enzyme dysfunction, leading to “intoxication” with a precursor in the metabolic pathway was vital to linking genetics and metabolic disorders and developing screening and treatment approaches as described in other chapters in this issue.
    [Show full text]
  • Orphanet Report Series Rare Diseases Collection
    Marche des Maladies Rares – Alliance Maladies Rares Orphanet Report Series Rare Diseases collection DecemberOctober 2013 2009 List of rare diseases and synonyms Listed in alphabetical order www.orpha.net 20102206 Rare diseases listed in alphabetical order ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 289157 1-alpha-hydroxylase deficiency 309127 3-hydroxyacyl-CoA dehydrogenase 228384 5q14.3 microdeletion syndrome deficiency 293948 1p21.3 microdeletion syndrome 314655 5q31.3 microdeletion syndrome 939 3-hydroxyisobutyric aciduria 1606 1p36 deletion syndrome 228415 5q35 microduplication syndrome 2616 3M syndrome 250989 1q21.1 microdeletion syndrome 96125 6p subtelomeric deletion syndrome 2616 3-M syndrome 250994 1q21.1 microduplication syndrome 251046 6p22 microdeletion syndrome 293843 3MC syndrome 250999 1q41q42 microdeletion syndrome 96125 6p25 microdeletion syndrome 6 3-methylcrotonylglycinuria 250999 1q41-q42 microdeletion syndrome 99135 6-phosphogluconate dehydrogenase 67046 3-methylglutaconic aciduria type 1 deficiency 238769 1q44 microdeletion syndrome 111 3-methylglutaconic aciduria type 2 13 6-pyruvoyl-tetrahydropterin synthase 976 2,8 dihydroxyadenine urolithiasis deficiency 67047 3-methylglutaconic aciduria type 3 869 2A syndrome 75857 6q terminal deletion 67048 3-methylglutaconic aciduria type 4 79154 2-aminoadipic 2-oxoadipic aciduria 171829 6q16 deletion syndrome 66634 3-methylglutaconic aciduria type 5 19 2-hydroxyglutaric acidemia 251056 6q25 microdeletion syndrome 352328 3-methylglutaconic
    [Show full text]
  • Neutral Amino Acids in the Urine [5-7]
    "This is a non-final version of an article published in final form in Current Opinion in Nephrology and Hypertension 22.5 (2013): 539-544 ". Epithelial neutral amino acid transporters, lessons from mouse models Stefan Bröer Research School of Biology, Australian National University Author of correspondence: Name: Stefan Bröer Address: Research School of Biology Linnaeus Way 134 Australian National University Canberra, ACT 0200, Australia Telephone number: +61-2-6125-2540 Email address: [email protected] Abstract (200 words max.): Purpose of review: Epithelial neutral amino acid transporters have been identified at the molecular level in recent years. Mouse models have now established the crucial role of these transporters for systemic amino acid homeostasis. The review summarises recent progress in this field. Recent findings: Epithelial neutral amino acid transporters play an important role in the homeostasis of neutral amino acid levels in the body. They are important for the maintenance of body weight, muscle mass and serve as fuels. They also serve a role in providing nutrients to epithelial cells. Changes of plasma amino acid levels are not necessarily correlated to the amino acids appearing in the urine, changes to organ amino acid metabolism need to be taken into account. Summary: Genetic deletion of neutral amino acid transporters provides insight into their role in protein nutrition and homestasis. Keywords: Protein nutrition, intestine, kidney Abbreviations: dss, dextran-sulphate; hpd, high protein diet; nd, normal diet Introduction The majority of epithelial amino acid transporters have been identified in recent years [1-3]. Many of these are expressed in both intestinal and renal epithelia (Fig.
    [Show full text]
  • Hartnup Disease
    Hartnup disease Description Hartnup disease is a condition caused by the body's inability to absorb certain protein building blocks (amino acids) from the diet. As a result, affected individuals are not able to use these amino acids to produce other substances, such as vitamins and proteins. Most people with Hartnup disease are able to get the vitamins and other substances they need with a well-balanced diet. People with Hartnup disease have high levels of various amino acids in their urine ( aminoaciduria). For most affected individuals, this is the only sign of the condition. However, some people with Hartnup disease have episodes during which they exhibit other signs, which can include skin rashes; difficulty coordinating movements ( cerebellar ataxia); and psychiatric symptoms, such as depression or psychosis. These episodes are typically temporary and are often triggered by illness, stress, nutrient-poor diet, or fever. These features tend to go away once the trigger is remedied, although the aminoaciduria remains. In affected individuals, signs and symptoms most commonly occur in childhood. Frequency Hartnup disease is estimated to affect 1 in 30,000 individuals. Causes Hartnup disease is caused by mutations in the SLC6A19 gene. This gene provides instructions for making a protein called B0AT1, which is primarily found embedded in the membrane of intestine and kidney cells. The function of this protein is to transport certain amino acids into cells. In the intestines, amino acids from food are transported into intestinal cells then released into the bloodstream so the body can use them. In the kidneys, amino acids are reabsorbed into the bloodstream instead of being removed from the body in urine.
    [Show full text]
  • Diagnosis and Treatment of Tyrosinosis
    Arch Dis Child: first published as 10.1136/adc.43.231.540 on 1 October 1968. Downloaded from Arch. Dis. Childh., 1968, 43, 540. Diagnosis and Treatment of Tyrosinosis ANGELA FAIRNEY, DOROTHY FRANCIS, R. S. ERSSER, J. W. T. SEAKINS, and DENNIS COTTOM From the Department ofChemical Pathology, Institute ofChild Health and The Hospitalfor Sick Children, London W.C.1 This paper describes the diagnosis of tyrosinosis A clean specimen of urine gave a deposit showing scanty in a girl aged 10 months. Her subsequent pro- pus cells, with a mixed growth on culture. X-rays gress after the institution of a diet low in phenyl- showed changes of rickets in the knees and anterior alanine and tyrosine has been good, and details of ends of the ribs and femora. An intravenous pyelogram showed enlarged kidneys with prompt excretion of the her treatment are discussed. dye; there was stretching of the calyces in the left and Tyrosinosis is an inherited metabolic disorder possibly in the right, which was suggestive of the adult characterized by cirrhosis, severe hypophosphat- type of polycystic disease. There was no clear sign of a aemic rickets, renal tubular defects, and a derange- focal lesion or paroxysmal features on the EEG. ment of tyrosine metabolism. The metabolic Biochemical results are listed in Table I. With the products arising from the deranged tyrosine exception of tyrosine, the plasma amino acid pattern metabolism point to a lack of p-hydroxyphenyl- was within the normal range, and in particular methio- pyruvate oxidase (Halvorsen, 1967). nine was never raised (normal approx.
    [Show full text]
  • Omics Knowledgebase for Mammalian Cellular Signaling Pathways
    bioRxiv preprint doi: https://doi.org/10.1101/401729; this version posted August 27, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The Signaling Pathways Project: an integrated ‘omics knowledgebase for mammalian cellular signaling pathways Scott Ochsner, David Abraham*, Kirt Martin*, Wei Ding, Apollo McOwiti, Zichen Wang, Kaitlyn Andreano, Ross A. Hamilton, Yue Chen, Angelica Hamilton, Marin L. Gantner, Michael Dehart, Shijing Qu, Susan G. Hilsenbeck, Lauren B. Becnel, Dave Bridges, Avi Ma’ayan, Janice M. Huss, Fabio Stossi, Charles E. Foulds, Anastasia Kralli, Donald P. McDonnell and Neil J. McKenna Address Correspondence To: Neil J. McKenna Department of Molecular and Cellular Biology Baylor College of Medicine Houston, TX 77030 USA e: [email protected] t: 713-798-8568 *These authors contributed equally to this study 1 bioRxiv preprint doi: https://doi.org/10.1101/401729; this version posted August 27, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Summary Public transcriptomic and ChIP-Seq datasets have the potential to illuminate facets of transcriptional regulation by mammalian cellular signaling pathways not yet explored in the research literature. Unfortunately, a variety of obstacles prevent routine re-use of these datasets by bench biologists for hypothesis generation and data validation. Here, we designed a web knowledgebase, the Signaling Pathways Project (SPP), which incorporates stable community classifications of three major categories of cellular signaling pathway node (receptors, enzymes and transcription factors) and the bioactive small molecules (BSMs) known to modulate their functions.
    [Show full text]
  • Treatable Inborn Errors of Metabolism Presenting As Cerebral Palsy Mimics
    Leach et al. Orphanet Journal of Rare Diseases 2014, 9:197 http://www.ojrd.com/content/9/1/197 RESEARCH Open Access Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review Emma L Leach1,2, Michael Shevell3,4,KristinBowden2, Sylvia Stockler-Ipsiroglu2,5,6 and Clara DM van Karnebeek2,5,6,7,8* Abstract Background: Inborn errors of metabolism (IEMs) have been anecdotally reported in the literature as presenting with features of cerebral palsy (CP) or misdiagnosed as ‘atypical CP’. A significant proportion is amenable to treatment either directly targeting the underlying pathophysiology (often with improvement of symptoms) or with the potential to halt disease progression and prevent/minimize further damage. Methods: We performed a systematic literature review to identify all reports of IEMs presenting with CP-like symptoms before 5 years of age, and selected those for which evidence for effective treatment exists. Results: We identified 54 treatable IEMs reported to mimic CP, belonging to 13 different biochemical categories. A further 13 treatable IEMs were included, which can present with CP-like symptoms according to expert opinion, but for which no reports in the literature were identified. For 26 of these IEMs, a treatment is available that targets the primary underlying pathophysiology (e.g. neurotransmitter supplements), and for the remainder (n = 41) treatment exerts stabilizing/preventative effects (e.g. emergency regimen). The total number of treatments is 50, and evidence varies for the various treatments from Level 1b, c (n = 2); Level 2a, b, c (n = 16); Level 4 (n = 35); to Level 4–5 (n = 6); Level 5 (n = 8).
    [Show full text]
  • Molecular Patterns Behind Immunological and Metabolic Alterations in Lysinuric Protein Intolerance
    MOLECULAR PATTERNS BEHIND IMMUNOLOGICAL AND METABOLIC ALTERATIONS IN LYSINURIC PROTEIN INTOLERANCE Johanna Kurko TURUN YLIOPISTON JULKAISUJA – ANNALES UNIVERSITATIS TURKUENSIS Sarja - ser. D osa - tom. 1220 | Medica - Odontologica | Turku 2016 University of Turku Faculty of Medicine Institute of Biomedicine Department of Medical Biochemistry and Genetics Turku Doctoral Programme of Molecular Medicine (TuDMM) Supervised by Adjunct Professor Juha Mykkänen, Ph.D Professor Harri Niinikoski, MD, Ph.D Research Centre of Applied and Department of Paediatrics and Preventive Cardiovascular Medicine Adolescent Medicine University of Turku Turku University Hospital Turku, Finland University of Turku Turku, Finland Reviewed by Adjunct Professor Risto Lapatto, MD, Ph.D Adjunct Professor Outi Monni, Ph.D Department of Paediatrics Research Programs’ Unit and Institute of Helsinki University Hospital Biomedicine University of Helsinki University of Helsinki Helsinki, Finland Helsinki, Finland Opponent Adjunct Professor Päivi Saavalainen, Ph.D Research Programs Unit University of Helsinki Helsinki, Finland The originality of this thesis has been checked in accordance with the University of Turku quality assurance system using the Turnitin OriginalityCheck service. ISBN 978-951-29-6399-7 (PRINT) ISBN 978-951-29-6400-0 (PDF) ISSN 0355-9483 (PRINT) ISSN 2343-3213 (ONLINE) Painosalama Oy - Turku, Finland 2016 ‘Nothing has such power to broaden the mind as the ability to investigate systematically and truly all that comes under thy observation in life.’ Marcus
    [Show full text]
  • Hartnup Disease in Psychiatric Practice: Clinical and Biochemical Features of Three Cases by L
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.23.1.40 on 1 February 1960. Downloaded from J. Neurol. Neurosurg. Psychiat., 1960, 23, 40. HARTNUP DISEASE IN PSYCHIATRIC PRACTICE: CLINICAL AND BIOCHEMICAL FEATURES OF THREE CASES BY L. A. HERSOV* and R. RODNIGHT From the Maudsley Hospital, London In a previous paper the case history was given of abnormality and examination of her family revealed a 10-year-old boy admitted to hospital for a an affected sister. The present paper describes the psychotic illness associated with a photosensitive follow-up of our original case for six years, together skin rash (Hersov, 1955). The condition resembled with as much information on his family as it has classical pellagra, and although no dietary reason been possible to obtain, and the clinical and bio- for a vitamin deficiency was apparent, a good chemical features of the second family. A pre- response was obtained to treatment with nicotin- liminary report of some of the biochemical data has amide. Biochemical investigations revealed gross already been given (Rodnight, 1959a). and persistent indicanuria and it was suggested by Rodnight and Mcllwain (1955), who studied this Case Reports guest. Protected by copyright. aspect of the illness, that the nicotinamide deficiency Family A.-This is the family of the boy (M.H.) whose might be due to a diversion of trytophan from its first attack of Hartnup disease has already been described by one of us (Hersov, 1955). The parents are not related. normal route of nicotinamide formation into that of The incidence of amino-aciduria in the family is given in indican formation.
    [Show full text]
  • Inborn Errors of Metabolism As a Cause of Neurological Disease in Adults: an Approach to Investigation
    J Neurol Neurosurg Psychiatry 2000;69:5–12 5 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.69.1.5 on 1 July 2000. Downloaded from REVIEW Inborn errors of metabolism as a cause of neurological disease in adults: an approach to investigation R G F Gray, M A Preece, S H Green, W Whitehouse, J Winer, A Green In 1927 Archibald Garrod presented the Hux- LYSOSOMAL STORAGE DISEASES ley Lecture at Charing Cross Hospital1 Out of The lysosome is an intracellular organelle this lecture emerged the concept of an “inborn involved in the degradation of various complex error of metabolism” whereby an inherited lipids, glycoproteins, and mucopolysaccha- defect may lead to the accumulation in cells or rides. Defects in specific enzymes lead to the body fluids of a metabolite which in itself may accumulation of complex catabolic intermedi- predispose to disease. The disorders cited as ates. Although the process occurs in utero the examples were all adult onset disorders. age of onset of clinical symptoms can vary sub- Today there are over 200 known inborn stantially. Alleles are known which are associ- errors of metabolism; however, the vast major- ated with a milder, later onset phenotype. This ity of cases reported are of childhood onset may be related to the presence of significant (<16 years of age). In part this may reflect the residual functional enzyme activity resulting in fact that the paediatric forms of the disease are a lower rate of accumulation of the intermedi- more severe and hence more easily recognis- ate metabolite. The clinical symptoms of the able.
    [Show full text]
  • Table I. Genodermatoses with Known Gene Defects 92 Pulkkinen
    92 Pulkkinen, Ringpfeil, and Uitto JAM ACAD DERMATOL JULY 2002 Table I. Genodermatoses with known gene defects Reference Disease Mutated gene* Affected protein/function No.† Epidermal fragility disorders DEB COL7A1 Type VII collagen 6 Junctional EB LAMA3, LAMB3, ␣3, ␤3, and ␥2 chains of laminin 5, 6 LAMC2, COL17A1 type XVII collagen EB with pyloric atresia ITGA6, ITGB4 ␣6␤4 Integrin 6 EB with muscular dystrophy PLEC1 Plectin 6 EB simplex KRT5, KRT14 Keratins 5 and 14 46 Ectodermal dysplasia with skin fragility PKP1 Plakophilin 1 47 Hailey-Hailey disease ATP2C1 ATP-dependent calcium transporter 13 Keratinization disorders Epidermolytic hyperkeratosis KRT1, KRT10 Keratins 1 and 10 46 Ichthyosis hystrix KRT1 Keratin 1 48 Epidermolytic PPK KRT9 Keratin 9 46 Nonepidermolytic PPK KRT1, KRT16 Keratins 1 and 16 46 Ichthyosis bullosa of Siemens KRT2e Keratin 2e 46 Pachyonychia congenita, types 1 and 2 KRT6a, KRT6b, KRT16, Keratins 6a, 6b, 16, and 17 46 KRT17 White sponge naevus KRT4, KRT13 Keratins 4 and 13 46 X-linked recessive ichthyosis STS Steroid sulfatase 49 Lamellar ichthyosis TGM1 Transglutaminase 1 50 Mutilating keratoderma with ichthyosis LOR Loricrin 10 Vohwinkel’s syndrome GJB2 Connexin 26 12 PPK with deafness GJB2 Connexin 26 12 Erythrokeratodermia variabilis GJB3, GJB4 Connexins 31 and 30.3 12 Darier disease ATP2A2 ATP-dependent calcium 14 transporter Striate PPK DSP, DSG1 Desmoplakin, desmoglein 1 51, 52 Conradi-Hu¨nermann-Happle syndrome EBP Delta 8-delta 7 sterol isomerase 53 (emopamil binding protein) Mal de Meleda ARS SLURP-1
    [Show full text]